| Wallace, Mark |
| Completed | 4 | 1014 | US | Enhanced Self-Care (ESC), Acceptance and Commitment Therapy (ACT), Evidence-Based Exercise and Manual Therapy (EBEM), Duloxetine, Cymbalta | University of North Carolina, Chapel Hill, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Chronic Low-back Pain | 07/24 | 10/24 | | |
| Active, not recruiting | 3 | 409 | Europe, US | Qutenza (capsaicin) 8% topical system, capsaicin 0.04% topical system | Averitas Pharma, Inc., Averitas Pharma, Inc. | Post Surgical Neuropathic Pain | 01/25 | 08/25 | | |
NCT05025787: A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain. |
|
|
| Completed | 2 | 77 | US | CNTX-6970, Placebo | Maurizio Fava, MD | Knee Osteoarthritis | 06/24 | 06/24 | | |
NCT06243835: A Study to Test the Effects of Kindolor At Different Doses in Healthy Adults |
|
|
| Active, not recruiting | 1 | 32 | US | Kindolor Tosylate, DCUKA, Placebo, Placebo to Match | Lohocla Research Corporation, National Institute on Drug Abuse (NIDA) | Chronic Pain | 07/25 | 07/25 | | |
NCT06633562: A Study to Test the Effects of Nezavist At Different Doses in Healthy Adults |
|
|
| Not yet recruiting | 1 | 32 | US | Nezavist SDD, DCUK-OEt, Placebo, Microcrystalline Cellulose | Lohocla Research Corporation, National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Healthy, Safety Evaluation of Escalating Doses, Tolerability | 09/25 | 12/25 | | |
NCT05438264: Effect of Donepezil on Speech Recognition in Cochlear Implant Users |
|
|
| Recruiting | 1 | 50 | US | Donepezil, Aricept, Placebo | Vanderbilt University Medical Center | Bilateral Sensorineural Hearing Loss | 09/25 | 09/25 | | |
